LEADER 03475nam  22006735  450 
001 9911031627203321
005 20251008131353.0
010   $a3-032-00773-9
024 7 $a10.1007/978-3-032-00773-5
035   $a(CKB)41571672300041
035   $a(MiAaPQ)EBC32333423
035   $a(Au-PeEL)EBL32333423
035   $a(OCoLC)1545123906
035   $a(DE-He213)978-3-032-00773-5
035   $a(EXLCZ)9941571672300041
100   $a20251008d2025      u|         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCancer Personalized Treatment $eNanomedicine, Combined Therapy, and Artificial Intelligence in Treatment of Tumors /$fedited by Nima Rezaei
205   $a1st ed. 2025.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2025.
215   $a1 online resource (1251 pages)
225 1 $aHandbook of Cancer and Immunology,$x3091-3675 ;$v9
311 08$a3-032-00772-0 
327   $aIntroduction on Personalized Immune-Oncology -- Advancing Precision Medicine -- Quantum Medicine and the Immune System -- The Role of Post- Translational Modifications in Cancer -- The Hurdle of Precision Medicine in Cancer Immunotherapy Personalization Now or Then.-Beyond Histology and Stage The ?Signatures? to Personalize Immunotherapy -- Personalized Cancer Vaccines Targeting Neoantigens -- Tissue Engineering and Regenerative Medicine in Cancer Therapy -- Nanomedicine Applications in Cancer Treatment -- Nanodelivery in Gene Therapy.
330   $aThe rapid flow of studies in the field of cancer and immunology during the last decades has increased our understanding of the interactions between the immune system and cancerous cells. In particular, it has been well-known that such interactions result in the induction of epigenetic changes in cancerous cells and the selection of less immunogenic clones as well as alterations in immune responses. Understanding the crosstalk between nascent transformed cells and cells of the immune system has led to the development of combinatorial immunotherapeutic strategies to combat cancer. The Handbook of Cancer and Immunology offers a comprehensive and up-to-date review of cancer immunology and immunotherapy, emphasizing key findings and clinically relevant data. This reference work is an essential resource for researchers, students, academics, and clinicians committed to advancing knowledge, diagnostics, and treatments in this vital field.
410  0$aHandbook of Cancer and Immunology,$x3091-3675 ;$v9
606   $aCancer
606   $aImmunology
606   $aImmunotherapy
606   $aTumors$xImmunological aspects
606   $aCancer$xTreatment
606   $aCancer Biology
606   $aImmunology
606   $aImmunotherapy
606   $aTumour Immunology
606   $aCancer Therapy
615  0$aCancer.
615  0$aImmunology.
615  0$aImmunotherapy.
615  0$aTumors$xImmunological aspects.
615  0$aCancer$xTreatment.
615 14$aCancer Biology.
615 24$aImmunology.
615 24$aImmunotherapy.
615 24$aTumour Immunology.
615 24$aCancer Therapy.
676   $a616.994061
700   $aRezaei$b Nima$0913363
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911031627203321
996   $aCancer Personalized Treatment$94444821
997   $aUNINA